Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.

Journal article

Bešević J. et al, (2023), Journal of epidemiology and community health

Swab pooling enables rapid expansion of high-throughput capacity for SARS-CoV-2 community testing.

Journal article

Fagg J. et al, (2023), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 167

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.

Journal article

Sonnenkalb L. et al, (2023), The Lancet. Microbe, 4, e358 - e368

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial

Journal article

Llewelyn MJ. et al, (2023), The Lancet Infectious Diseases, 23, 207 - 221

Performance of self-collected saliva samples for SARS-CoV-2 mass testing in community settings

Journal article


Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records

Journal article

Yoon CH. et al, (2022), Journal of Antimicrobial Chemotherapy, 77, 2536 - 2545

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

Journal article

Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom

Journal article

Vihta1 KD. et al, (2022), Clinical Infectious Diseases

Load More